B
Bettina K. Doering
Researcher at The Catholic University of America
Publications - 71
Citations - 1566
Bettina K. Doering is an academic researcher from The Catholic University of America. The author has contributed to research in topics: Grief & Anxiety. The author has an hindex of 18, co-authored 61 publications receiving 1093 citations. Previous affiliations of Bettina K. Doering include University of Mainz & University of Marburg.
Papers
More filters
Journal ArticleDOI
A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment.
TL;DR: A meta‐analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment concludes that antidepressant treatment should be considered as a second line of treatment.
Journal ArticleDOI
Patients’ Expectations Predict Surgery Outcomes: A Meta-Analysis
Charlotte J. Auer,Julia Anna Glombiewski,Bettina K. Doering,Alexander Winkler,Johannes A. C. Laferton,Elizabeth Broadbent,Winfried Rief +6 more
TL;DR: The results confirm the importance of patients’ expectations in the prediction of postsurgical outcomes and underline the necessity to optimize these expectations in order to improve postoperative quality of life.
Journal ArticleDOI
Utilizing placebo mechanisms for dose reduction in pharmacotherapy
Bettina K. Doering,Winfried Rief +1 more
TL;DR: Designs for clinical trials that seem appropriate to the investigation of conditioned placebo effects in pharmacotherapy are discussed, including classic and instrumental conditioning processes that involve both conscious and non-conscious information processing.
Journal ArticleDOI
The Cyberchondria Severity Scale (CSS): German Validation and Development of a Short Form.
TL;DR: The German version of the CSS possesses very good psychometric characteristics, which were preserved in a short version, and the correlations with health anxiety and depression for both scales underscore their validity and clinical relevance.
Journal ArticleDOI
Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials
TL;DR: Focusing on efficacy, clinicians should favor benzodiazepine receptor agonists and classical Benzodiazepines over antidepressants over antidepressants (including low-dose doxepin) for primary insomnia treatment, but the additional consideration of different side effect profiles can lead to alternative treatment decisions.